We are live on ! Find out more
PP

Paloma Partners Portfolio holdings

AUM $510M
1-Year Est. Return 286.05%
This Fund
S&P 500
This Quarter Est. Return
+5.02%
1 Year Est. Return
+286.05%
3 Year Est. Return
+321.92%
5 Year Est. Return
+284.54%
10 Year Est. Return
+855.7%
AUM
$3.78B
AUM Growth
-$541M
Cap. Flow
-$699M
Cap. Flow %
-18.5%
Top 10 Hldgs %
26.03%
Holding
2,134
New
570
Increased
494
Reduced
496
Closed
467

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$28.7M
2
FXE icon
Invesco CurrencyShares Euro Currency Trust
FXE
+$23.2M
3
BIIB icon
Biogen
BIIB
+$20.8M
4
NKE icon
Nike
NKE
+$18.3M
5
IBM icon
IBM
IBM
+$17.2M

Top Sells

Rank Stock Value
1
SIAL
SIGMA - ALDRICH CORP
SIAL
+$48.6M
2
JPM icon
JPMorgan Chase
JPM
+$47.9M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$46.2M
4
TRAK
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
+$31.6M
5
KIM icon
Kimco Realty
KIM
+$26.9M

Sector Composition

Rank Sector Weight
1 Healthcare 6.62%
2 Industrials 6.54%
3 Financials 6.19%
4 Technology 6.15%
5 Consumer Discretionary 5.62%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BMRN icon
1701
BioMarin Pharmaceuticals
BMRN
$11.7B
– –
-10,009
Closed -$1.05M
BR icon
1702
Broadridge
BR
$17.9B
– –
-23,522
Closed -$1.3M
BRC icon
1703
Brady Corp
BRC
$4.39B
– –
-13,818
Closed -$272K
BTE icon
1704
Baytex Energy
BTE
$3.04B
– –
-49,723
Closed -$159K
BTI icon
1705
British American Tobacco
BTI
$133B
– –
-3,996
Closed -$220K
BUD icon
1706
AB InBev
BUD
$166B
– –
-4,449
Closed -$473K
BWA icon
1707
BorgWarner
BWA
$13.2B
– –
-22,576
Closed -$827K
BXMT icon
1708
Blackstone Mortgage Trust
BXMT
$2.53B
– –
-27,246
Closed -$748K
CBOE icon
1709
Cboe Global Markets
CBOE
$31B
– –
-15,211
Closed -$1.02M
CC icon
1710
Chemours
CC
$2.57B
– –
-11,736
Closed -$75K
CE icon
1711
PUT
Celanese
CE
$4.91B
– –
-8,600
Closed -$509K
CERS icon
1712
Cerus
CERS
$579M
– –
-12,600
Closed -$57K
CHE icon
1713
Chemed
CHE
$7.1B
– –
-1,678
Closed -$223K
CHRD icon
1714
Chord Energy
CHRD
$7.78B
– –
-12,914
Closed -$112K
CIEN icon
1715
Ciena
CIEN
$52.7B
– –
-9,900
Closed -$205K
CLDT
1716
Chatham Lodging
CLDT
$622M
– –
-32,484
Closed -$697K
CLX icon
1717
Clorox
CLX
$11.7B
– –
-25,775
Closed -$2.98M
CMI icon
1718
CALL
Cummins
CMI
$87.3B
– –
-55,600
Closed -$6.04M
CMI icon
1719
Cummins
CMI
$87.3B
– –
-34,409
Closed -$3.74M
CMI icon
1720
PUT
Cummins
CMI
$87.3B
– –
-38,500
Closed -$4.18M
CNMD icon
1721
CONMED
CNMD
$1.41B
– –
-8,274
Closed -$395K
CNP icon
1722
CenterPoint Energy
CNP
$27.8B
– –
-14,596
Closed -$264K
COP icon
1723
PUT
ConocoPhillips
COP
$145B
– –
-26,000
Closed -$1.25M
CORT icon
1724
Corcept Therapeutics
CORT
$12.7B
– –
-15,225
Closed -$58K
CPA icon
1725
Copa Holdings
CPA
$5.8B
– –
-6,542
Closed -$274K
67 68
69
70 71

Similar funds

PWMG
Prestige Wealth Management Group Flemington, New Jersey $509M AUM 15.69% 1-Year Est. Return
NIEF
Nalanda India Equity Fund Mauritius $510M AUM 23.61% 1-Year Est. Return
HIM
HughesLittle Investment Management Vancouver $511M AUM 24.72% 1-Year Est. Return
MCA
Magnolia Capital Advisors Jackson, Mississippi $509M AUM 18.99% 1-Year Est. Return
MC
Machina Capital Paris, France $508M AUM 9.91% 1-Year Est. Return
CTAF
Call To Action Foundation Salt Lake City, Utah $511M AUM 16.28% 1-Year Est. Return
MWAM
Manhattan West Asset Management Los Angeles, California $511M AUM 18.81% 1-Year Est. Return
MCM
Maltese Capital Management New York $508M AUM 21.31% 1-Year Est. Return

Paloma Partners's Q4 2015 Portfolio in Review

As of Q4 2015, Paloma Partners held 2,134 positions worth $3.78B, down 13% from $4.32B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Paloma Partners withdrew a net $699M in Q4 2015, closing 467 positions and reducing 496 holdings. Its most notable exit was SIGMA - ALDRICH CORP, an estimated $48.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 6.6% of assets, up from 5.8% a quarter earlier, followed by Industrials and Financials.

Against the trend, Paloma Partners opened a new position in Allergan plc worth $30.1M.

  • Paloma Partners's largest Q4 2015 buy was Allergan plc: 96,344 shares worth $30.1M.
  • Paloma Partners added most to Biogen in Q4 2015, an estimated $20.8M increase.
  • Paloma Partners's biggest Q4 2015 reduction was Regeneron Pharmaceuticals, cutting an estimated $46.2M.
  • Paloma Partners fully exited SIGMA - ALDRICH CORP in Q4 2015, selling an estimated $48.6M.
  • Paloma Partners's ten largest holdings make up 26% of its $3.78B portfolio in Q4 2015.
  • Paloma Partners opened 570 new positions and closed 467 in Q4 2015.
  • Paloma Partners's portfolio value fell 13% quarter-over-quarter to $3.78B.

Based on Paloma Partners's 13F filing for Q4 2015, filed 16 Feb 2016.